In addition, it is possible that deeper phenotyping of patients, including a broader set of phenotypic traits, may more precisely distinguish between various subtypes of diabetes (e.g. analysing multiple islet cell autoantibodies, not just GAD65, in the ANDIS classification). This evidence concerns the gene GAD2 and diabetes mellitus.